E Fund Management Co., Ltd.

SEC CIK: 0001842296
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

JANX holding history

Janux Therapeutics, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

JANX overview All 13F holders of JANX Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2024

Holdings of JANX by E Fund Management Co., Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−68,644−100.0%	Sold out	Holders
Q1 2025	68,644	$1.85M	0.1%	+4,076+6.3%	Added	Holders
Q4 2024	64,568	$3.46M	0.2%	−530−0.8%	Reduced	Holders
Q3 2024	65,098	$2.96M	0.2%	+65,098	New	Holders